Skip to main content

Technologies (Archived)

25 results found
Electronics & Instrumentation Pharmaceuticals / Nutraceuticals Physics
Technologies
ID: 2019-015 Recombinant human Gal-1 treatment improves membrane repair capacity, increases myogenic markers and decreases inflammation in dysferlin deficient myotubes, providing novel evidence regarding how Gal-1 favorably improves muscle function in LGMD2B.
Technologies
ID: 2020-047 Method to assess risk for late-in-life amyloidosis allowing for early diagnosis and prevention
Technologies
ID: 2018-037 SYSTEM AND METHOD FOR TREATING A DISEASE OR BACTERIAL INFECTION - BYSTANDER PHAGE THERAPY
Technologies
ID: 2014-098 Blood dopamine D2 receptors as biomarkers for brain dopamine